Highlights
NASDAQ: HALO       Halozyme Therapeutic
Last Price Today's Change   Day's Range   Trading Volume
18.885   -0.025 (0.13%)  18.47 - 18.96  2,433,787

Overview

 
Avg Volume (4 weeks):2,623,915
4 Weeks Range:14.61 - 19.05
4 Weeks Price Volatility (%):
96.28%
52 Weeks Range:13.24 - 19.05
52 Weeks Price Volatility (%):
97.16%
Average Price Target: 6.50
Price Target Upside/Downside: -12.385

Headlines



No recent Headlines for this stock.


Business Background

Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

  Be the first to like this.
 


 

2604  3075  374  2926 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.644-0.057 
 AMD 39.88+1.32 
 ACB 2.28-0.45 
 I 8.03-5.38 
 AABA 19.630.00 
 GE 11.44-0.08 
 UBER 26.75-0.04 
 AMRN 22.60-1.42 
 F 8.950.00 
 SNAP 14.69+0.75 
Partners & Brokers